Class information for:
Level 1: PALIPERIDONE PALMITATE//LONG ACTING RISPERIDONE//OLANZAPINE PAMOATE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
6150 1458 35.0 69%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
278 18430 RISPERIDONE//CLOZAPINE//OLANZAPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PALIPERIDONE PALMITATE Author keyword 56 71% 3% 45
2 LONG ACTING RISPERIDONE Author keyword 46 78% 2% 31
3 OLANZAPINE PAMOATE Author keyword 38 93% 1% 14
4 LONG ACTING INJECTION Author keyword 36 71% 2% 29
5 RISPERIDONE LONG ACTING INJECTION Author keyword 33 83% 1% 19
6 LONG ACTING INJECTABLE Author keyword 33 67% 2% 29
7 OLANZAPINE LONG ACTING INJECTION Author keyword 21 90% 1% 9
8 DEPOT Author keyword 19 38% 3% 41
9 LONG ACTING INJECTABLE RISPERIDONE Author keyword 17 75% 1% 12
10 LONG ACTING INJECTABLE ANTIPSYCHOTICS Author keyword 15 77% 1% 10

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PALIPERIDONE PALMITATE 56 71% 3% 45 Search PALIPERIDONE+PALMITATE Search PALIPERIDONE+PALMITATE
2 LONG ACTING RISPERIDONE 46 78% 2% 31 Search LONG+ACTING+RISPERIDONE Search LONG+ACTING+RISPERIDONE
3 OLANZAPINE PAMOATE 38 93% 1% 14 Search OLANZAPINE+PAMOATE Search OLANZAPINE+PAMOATE
4 LONG ACTING INJECTION 36 71% 2% 29 Search LONG+ACTING+INJECTION Search LONG+ACTING+INJECTION
5 RISPERIDONE LONG ACTING INJECTION 33 83% 1% 19 Search RISPERIDONE+LONG+ACTING+INJECTION Search RISPERIDONE+LONG+ACTING+INJECTION
6 LONG ACTING INJECTABLE 33 67% 2% 29 Search LONG+ACTING+INJECTABLE Search LONG+ACTING+INJECTABLE
7 OLANZAPINE LONG ACTING INJECTION 21 90% 1% 9 Search OLANZAPINE+LONG+ACTING+INJECTION Search OLANZAPINE+LONG+ACTING+INJECTION
8 DEPOT 19 38% 3% 41 Search DEPOT Search DEPOT
9 LONG ACTING INJECTABLE RISPERIDONE 17 75% 1% 12 Search LONG+ACTING+INJECTABLE+RISPERIDONE Search LONG+ACTING+INJECTABLE+RISPERIDONE
10 LONG ACTING INJECTABLE ANTIPSYCHOTICS 15 77% 1% 10 Search LONG+ACTING+INJECTABLE+ANTIPSYCHOTICS Search LONG+ACTING+INJECTABLE+ANTIPSYCHOTICS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INJECTABLE RISPERIDONE 174 85% 6% 93
2 ORAL ANTIPSYCHOTICS 73 80% 3% 45
3 CONVENTIONAL DEPOT ANTIPSYCHOTICS 41 90% 1% 18
4 ANTIPSYCHOTIC MEDICATION 38 31% 7% 102
5 DEPOT ANTIPSYCHOTICS 38 62% 3% 39
6 PALIPERIDONE PALMITATE 35 89% 1% 16
7 DEPOT ANTIPSYCHOTIC DRUGS 32 85% 1% 17
8 COMPLIANCE THERAPY 32 52% 3% 44
9 LONG ACTING INJECTION 22 67% 1% 20
10 SUBJECTIVE RESPONSE 20 32% 4% 52

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders 2015 2 109 52%
Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance 2015 1 13 92%
Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia: A Systematic Review and Meta-Analysis of Mirror-Image Studies 2013 25 19 74%
Oral versus depot antipsychotic drugs for schizophrenia A critical systematic review and meta-analysis of randomised long-term trials 2011 116 34 32%
Approaches to improve adherence to pharmacotherapy in patients with schizophrenia 2014 5 39 72%
Medication Adherence: A Review of the Literature and Implications for Clinical Practice 2009 77 57 40%
Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review 2014 13 41 27%
A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia 2011 41 22 55%
Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review 2013 9 26 73%
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature 2002 509 64 48%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 IZOPHRENIA SERV 3 45% 0.3% 5
2 MED AFFAIRS EMEA 3 38% 0.4% 6
3 BIOMETR REPORTING 3 50% 0.3% 4
4 MANHATTAN PSYCHIAT 3 42% 0.3% 5
5 BIOSTAT MED INFORMAT MED 2 67% 0.1% 2
6 MED AFFAIRS PSYCHIAT 2 67% 0.1% 2
7 PSYCHOSIS CLIN 2 50% 0.2% 3
8 PSYCHIAT OUTPATIENT TREATMENT 2 40% 0.3% 4
9 PSYCHIAT UNIV POLIKLIN 2 40% 0.3% 4
10 LILLY USA 2 43% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000236002 INSIGHT//COGNITIVE INSIGHT//AWARENESS OF ILLNESS
2 0.0000229185 CLOZAPINE//RISPERIDONE//OLANZAPINE
3 0.0000189033 CLINICAL GLOBAL IMPRESSIONS SCALE//FUNCTIONAL REMISSION//SYMPTOMATIC REMISSION
4 0.0000133127 ANTIPSYCHOTIC POLYPHARMACY//POLYPHARMACY//TUNKU ABDUL RAHMAN NEUROSCI
5 0.0000129607 SECTOR NE//LANCASHIRE QUALITY OF LIFE PROFILE//QLDS
6 0.0000123180 REDUCED HALOPERIDOL//BROMPERIDOL//REDUCED BROMPERIDOL
7 0.0000095277 BROMATOL NUTR DIETET//ESTADES PRACT TUTELADES UNIT//CLIN PHARMACOL MED CARE
8 0.0000079030 EXPRESSED EMOTION//PERCEIVED CRITICISM//FIVE MINUTE SPEECH SAMPLE
9 0.0000076540 DURATION OF UNTREATED PSYCHOSIS//PRODROME//EARLY INTERVENTION IN PSYCHIATRY
10 0.0000073244 HYPOMANIC PERSONALITY//SPE UM MENTAL HLTH//SOCIAL RHYTHM METRIC